CACNA1B
protein-codingcalcium voltage-gated channel subunit alpha1 B, the group of Calcium voltage-gated channel alpha1 subunits|EF-hand domain containing
Gene summary
The protein encoded by this gene is the pore-forming subunit of an N-type voltage-dependent calcium channel, which controls neurotransmitter release from neurons. The encoded protein forms a complex with alpha-2, beta, and delta subunits to form the high-voltage activated channel. This channel is sensitive to omega-conotoxin-GVIA and omega-agatoxin-IIIA but insensitive to dihydropyridines. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2011]
- CACNL1A5
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~246.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0032784
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0032784
Submitter: Illumina
Inheritance Pattern: AR
Disease ID:MONDO:0032784
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0100516
Submitter: ClinGen
*CACNA1B* encodes the (α1B) pore-forming subunit of the N-type voltage-gated calcium channel. *CACNA1B* was first reported in relation to autosomal recessive complex neurodevelopmental disorder with motor features in 2019 (Gorman KM et al., PMID: 30982612). Four variants have been reported in 6 children from 3 unrelated families, in one publication; all probands presented with early onset epileptic encephalopathy, severe neurodevelopmental delay with regression, and hyperkinetic movement disorder (PMID: 30982612). A different publication reported on a proband with a compound deep intronic splicing variant and missense variant. However, due to the high variant frequencies in gnomAD, the pathogenicity of these variants is unclear and these were not scored (PMID: 37095367). To date, no experimental evidence supports the relationship between *CACNA1B* and AR complex neurodevelopmental disorder with motor features. In summary, there is MODERATE evidence to support this gene-disease relationship. The ClinGen Cerebral Palsy Working Group approved this classification on August 21, 2023 (SOP Version 9).
Inheritance Pattern: AR
Disease ID:MONDO:0032784
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0018614
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Cardiovascular; Neurologic
Intervention: Cardiovascular
Rationale: As the condition can include cardiac arrhythmias, awareness may allow surveillance and early management
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CACNA1B variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_000718.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 5 | 596 | 7 | 608 | ||
| missense | 647 | 50 | 2 | 699 | ||
| nonsense | 14 | 6 | 1 | 21 | ||
| start loss | 2 | 2 | ||||
| frameshift | 20 | 5 | 7 | 1 | 33 | |
| splice donor/acceptor (+/-2bp) | 1 | 15 | 16 | 3 | 35 | |
| Total | 35 | 26 | 678 | 650 | 9 | 1398 |
Highest pathogenic variant AF is 0.000006956416
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_000709.1 | 47 | MANE Select | |
| Ensembl | ENSP00000360423.1 | 47 | MANE Select | |
| RefSeq | NP_001230741.1 | 47 | Standard | |
| Ensembl | ENSP00000277551.2 | 47 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Synaptic vesicle cycle - Homo sapiens (human)
- Retrograde endocannabinoid signaling - Homo sapiens (human)
- GABAergic synapse - Homo sapiens (human)
- Serotonergic synapse - Homo sapiens (human)
- Dopaminergic synapse - Homo sapiens (human)
Biological Process
- calcium ion transport
- chemical synaptic transmission
- neurotransmitter secretion
- locomotory behavior
- regulation of heart contraction
Molecular Function
- amyloid-beta binding
- voltage-gated calcium channel activity
- calcium channel activity
- calcium ion binding
- protein binding
Cellular Component
- plasma membrane
- voltage-gated calcium channel complex
- dendrite
- neuronal cell body
- presynapse
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000371372
- Coding exons
- 47
- Length
- 246836
- Individuals with no LoFs
- 117913
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 6765
- Defined
- 124678
- p
- 0.0275
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 4.52 | 841 | 1.30e+3 | 0.647 | 0.0000821 | 15050 |
| Missense (PolyPhen) | 198 | 375.01 | 0.52799 | 4039 | ||
| Synonymous | -0.416 | 546 | 534 | 1.02 | 0.0000348 | 4663 |
| Loss of Function | 7.85 | 16 | 101 | 0.158 | 0.00000526 | 1179 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.024 | 0.021 | notable |
| Latino/Admixed American | 0.026 | 0.021 | notable |
| Ashkenazi Jewish | 0.056 | 0.045 | notable |
| East Asian | 0.019 | 0.017 | notable |
| Finnish | 0.027 | 0.022 | notable |
| European (Non-Finnish) | 0.035 | 0.030 | notable |
| South Asian | 0.044 | 0.036 | notable |
| Other | 0.029 | 0.025 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. The isoform alpha-1B gives rise to N-type calcium currents. N-type calcium channels belong to the 'high-voltage activated' (HVA) group and are specifically blocked by omega-conotoxin-GVIA (AC P01522) (AC P01522) (By similarity). They are however insensitive to dihydropyridines (DHP). Calcium channels containing alpha-1B subunit may play a role in directed migration of immature neurons. {ECO:0000250|UniProtKB:Q02294}.;
- Disease
- DISEASE: Dystonia 23 (DYT23) [MIM:614860]: A form of dystonia, a disorder defined by the presence of sustained involuntary muscle contraction, often leading to abnormal postures. DYT23 is an autosomal dominant dystonia affecting the face, neck, limbs. Some DYT23 patients manifest generalized myoclonus in addition to progressive action-induced multifocal dystonia. {ECO:0000269|PubMed:25296916}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.215
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.892
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | High | High | High |
| Primary Immunodeficiency | High | High | High |
| Cancer | High | High | High |